Author:
Miura Masaru,Miyata Koichi,Kaneko Tetsuji,Akahoshi Shogo,Morikawa Yoshihiko,Matsushima Takahiro,Sakakibara Hiroshi,Kobayashi Tohru,Nakamura Takahiro,Takahashi Tsutomu,Nakazawa Maki,Shibata Akimichi,Yamagishi Hiroyuki
Funder
Tokyo Metropolitan Hospitals in Japan
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927
2. Miura M, Ayusawa M, Fukazawa R, Hamada H, Ikeda S, Ito S et al (2021) Guidelines for medical treatment of acute Kawasaki disease (2020 revised version). J Pediatr Cardiol Card Surg 5:41–73
3. Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N et al (2018) Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr 172:e180030
4. Singh S, Vignesh P, Burgner D (2015) The epidemiology of Kawasaki disease: a global update. Arch Dis Child 100:1084–1088
5. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T et al (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606–2612